| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/25/2011 | CN102070608A 4-substituted phenylamino-7-substituted alkoxy-quinazoline derivant and preparation method and application thereof |
| 05/25/2011 | CN102070605A Imatinib mesylate polymorph and pharmaceutical composition |
| 05/25/2011 | CN102070599A Norsesquiterpenoid peralcohol and preparation method and application thereof |
| 05/25/2011 | CN102070598A Norsesquiterpenoid peroxides and preparation method thereof and antitumor use thereof |
| 05/25/2011 | CN102070595A Substituted benzoxanthone type compound and application thereof |
| 05/25/2011 | CN102070573A Mono-tetrahydrofuran type sugar apple lactone compound with anti-tumor activity and application thereof |
| 05/25/2011 | CN102070565A 4-alkyl-6-aryl-5-acetyl-1, 3-thiazine, and preparation method and application thereof |
| 05/25/2011 | CN102070556A 5-benzyl-4-alkyl-2-aminothiazole as well as preparation and application of 5-benzyl-4-alkyl-2-aminothiazole |
| 05/25/2011 | CN102070555A 3-(2-amino-ethyl)-5-(3-cyclohexyl-propylidene)-thiazoline-2,4-diketone and derivatives thereof |
| 05/25/2011 | CN102070541A Letrozole I-type crystal and preparation method thereof |
| 05/25/2011 | CN102070532A Anti-tumor medicament structure |
| 05/25/2011 | CN102070525A Tetrahydroisoquinoline derivatives and preparation method and application thereof |
| 05/25/2011 | CN102070510A 3-hydroxyindole derivatives and synthesis method and use thereof |
| 05/25/2011 | CN102070507A Tri-indole compound and preparation method and application thereof |
| 05/25/2011 | CN102070485A Method for separating and purifying active component aurantiamide acetate from traditional Chinese medicine clematis terniflora |
| 05/25/2011 | CN102070482A Derivatives of natural product S6-2, and preparation method and use thereof as anti-tumor medicines |
| 05/25/2011 | CN102070481A Medicine tromantadine with adamantane structure, anti-tumor application of derivates and analogs thereof having new indications |
| 05/25/2011 | CN102070463A Medicine memantine with adamantane structure, and derivative and analog thereof, and application to new antineoplastic indication |
| 05/25/2011 | CN102070432A Novel preparation method for hypocrellin B serving as photosensitizer |
| 05/25/2011 | CN102070429A Chalcone derivative, and preparing method and application thereof |
| 05/25/2011 | CN102068703A Doxorubicin multi-targeting drug delivery system and preparation method and application thereof |
| 05/25/2011 | CN102068702A Lactosyl-norcantharidin phospholipid compound and preparation method thereof |
| 05/25/2011 | CN102068664A Formula of traditional Chinese medicine for treating nasopharyngeal darcinoma |
| 05/25/2011 | CN102068641A Chinese medicinal capsules for treating gynecological diseases |
| 05/25/2011 | CN102068636A Herbal preparation for treating ascitic type liver cancer |
| 05/25/2011 | CN102068633A Formula of traditional Chinese medicament for treating rectal cancer postoperation complication and replacing radiotherapy and chemotherapy |
| 05/25/2011 | CN102068631A Medicinal composition for treating cancer and application thereof |
| 05/25/2011 | CN102068628A Anticancer traditional Chinese medicine soup |
| 05/25/2011 | CN102068584A Hydrophobic steroid saponin extract of peltate yam rhizome as well as preparation method and use thereof |
| 05/25/2011 | CN102068537A Production method for preparing health care foods and medicaments for preventing and treating nasopharyngeal darcinoma by using tangerine peel and liquoric root |
| 05/25/2011 | CN102068516A Traditional Chinese medicine for treating cancers and preparation method thereof |
| 05/25/2011 | CN102068509A Method for preparing pulsatilla chinensis (Bunge) Regel active ingredient, method for preparing preparation of pulsatilla chinensis (Bunge) Regel active ingredient and application of pulsatilla chinensis (Bunge) Regel active ingredient in preparation of antineoplastic medicament |
| 05/25/2011 | CN102068496A Radiosensitizer compositions comprising schisandra chinensis(turcz.)baill |
| 05/25/2011 | CN102068486A Effective fractions of cicer arietinum linn bean sprout and preparation method and application thereof |
| 05/25/2011 | CN102068485A Preparation and application of high-efficiency and low-toxicity effective fraction for suppressing angiogenesis in silktree albizzia bark |
| 05/25/2011 | CN102068481A Preparation and application of low-toxicity effective fraction for suppressing angiogenesis in cowherb seed |
| 05/25/2011 | CN102068477A Effective parts of ginseng and preparation method and application thereof |
| 05/25/2011 | CN102068470A Anticancer oral liquid preparation and main component preparation method thereof |
| 05/25/2011 | CN102068457A Application of ascites tumor cell in preparing bone cancer pain model |
| 05/25/2011 | CN102068448A Application of icariside II in preparation of anti-melanoma medicament |
| 05/25/2011 | CN102068447A Application of triterpenoid saponin compound in preparation of medicaments for treating autoimmune diseases |
| 05/25/2011 | CN102068436A Dihydroporphin photosensitizer and preparation and application thereof |
| 05/25/2011 | CN102068435A Composite fluorouracil anti-tumor medicament |
| 05/25/2011 | CN102068431A Carbazole sulfamide-derived anti-tumor medicine tablets and preparation method thereof |
| 05/25/2011 | CN102068430A 1,6-disubstituted-beta-carboline cyclin-dependent kinase 2/Raf kinase dual inhibitor and application thereof |
| 05/25/2011 | CN102068428A Dihydroporphin photosensitizer and preparation and application thereof |
| 05/25/2011 | CN102068422A Medical use of (S)-3-fluoro-2-(4-isobutyl phenyl) propionic acid |
| 05/25/2011 | CN102068419A Curcumin composition |
| 05/25/2011 | CN102068415A Carbazole sulfonamide anti-tumor medicine dispersible tablets and preparation method thereof |
| 05/25/2011 | CN102068411A Carbazole sulfonamide type anti-tumor medicament granules and preparation method thereof |
| 05/25/2011 | CN102068407A Cabazitaxel injection and preparation method thereof |
| 05/25/2011 | CN101744803B Method for preparing oridonin solid dispersion |
| 05/25/2011 | CN101703677B Application of composite of sweet wormwood herb and turtle shell in preparing antitumor medicine |
| 05/25/2011 | CN101670114B Compound of survivin and heat shock protein, preparation method and applications thereof |
| 05/25/2011 | CN101618221B Preparation method and application of functionalized nano-carbon tube anti-neoplastic drug carrier |
| 05/25/2011 | CN101584672B Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof |
| 05/25/2011 | CN101575315B New naphthalimide derivative, preparation method and application thereof |
| 05/25/2011 | CN101560214B 4-amino-6-phenyl-pyrrolo[2, 3-d]pyrimidine derivatives |
| 05/25/2011 | CN101497876B Recombinant adenovirus for expressing targetedly proliferating recombinant adenovirus for expressing proapoptosis gene and use thereof |
| 05/25/2011 | CN101492719B Uses of CXorf41 gene |
| 05/25/2011 | CN101486733B Oxygen-containing bridge dinuclear molybdenum cluster compound, and preparation and use thereof |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101457252B Application of E2F8 gene |
| 05/25/2011 | CN101444629B Non-injection gene therapy medicine and medicine box thereof |
| 05/25/2011 | CN101401789B Cordyceps sinensis polysaccharide liposome medicament and preparation thereof |
| 05/25/2011 | CN101374808B Indole sulfonamide modulators of progesterone receptors |
| 05/25/2011 | CN101336918B Use of annonaceous acetogenins in preparing medicine for treating lung cancer or breast cancer |
| 05/25/2011 | CN101321528B 3 , llb-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation |
| 05/25/2011 | CN101260135B Method for synthesizing higher fatty acid zidovudine ester |
| 05/25/2011 | CN101259180B Shenshe composition and preparation thereof |
| 05/25/2011 | CN101244104B Method for increasing rare saponin content in panax ginseng total saponin extract |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101171257B Pyrrolobenzodiazepines compound |
| 05/25/2011 | CN101133055B MELEIMId derivative for treating cancer, compositions and methods |
| 05/25/2011 | CN101100666B Human TCRVbeta7.1_H3F7 gene and its screening method and application |
| 05/25/2011 | CN101085349B Vesicle guiding immunocyte and application of the same in preparing antineoplastic medicine |
| 05/24/2011 | US7947812 Neoplasm specific antibodies and uses thereof |
| 05/24/2011 | US7947805 BCMA polypeptides and uses thereof |
| 05/24/2011 | US7947720 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 05/24/2011 | US7947706 Substituted pyrrolopyridines, compositions containing them, manufacturing process therefor and use thereof |
| 05/24/2011 | US7947705 7-azaindoles and the use thereof as therapeutic agents |
| 05/24/2011 | US7947695 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 05/24/2011 | US7947694 Substituted pyrazolo[3,4-D]pyrimidines as cell cycle kinase inhibitors |
| 05/24/2011 | US7947689 Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators |
| 05/24/2011 | US7947684 anticoagulants; immunomoderators; antiinflammatory agents |
| 05/24/2011 | US7947682 Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents |
| 05/24/2011 | US7947676 Pyrazolo[3,4-d]pyrimidine compounds as antitumor agents |
| 05/24/2011 | US7947674 Meso-substituted porphyrins |
| 05/24/2011 | US7947671 Synthesis of naturally occuring ecteinascidins and related compounds |
| 05/24/2011 | US7947668 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 05/24/2011 | US7947472 An expression vector comprising a sequence of human DNA encoding vascular endothelial growth factor-D (VEGF-D) or a fragment having the biological activity of VEGF-D, inserted into a mammalian expression vector |
| 05/24/2011 | US7947463 Diagnosing cancer; measure antibody inhibitor, compare to control, reduced amounts of inhibitor indicates receptivity to cancer |
| 05/24/2011 | US7947462 Methods for identifying Kremen polypeptide binding partners |
| 05/24/2011 | US7947452 Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses |
| 05/24/2011 | US7947312 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 05/24/2011 | US7947287 Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors |
| 05/24/2011 | US7947282 Methods of treatment using vascular occlusion in combination therapies |
| 05/24/2011 | US7947275 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |
| 05/24/2011 | US7947273 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma |
| 05/24/2011 | CA2493764C Improved treatment of cancer with glutamine |